News

IDIBELL and Bellvitge Hospital take the first step towards personalized medicine in kidney transplantation

The research group has managed to demonstrate the good results of an algorithm that adjusts the doses of the immunosuppressant tacrolimus according to the characteristics of each person. The results have been published in the scientific journal Kidney International.

Leer más about IDIBELL and Bellvitge Hospital take the first step towards personalized medicine in kidney transplantation

Scientists create a mouse model to study the progression of a type of leukemia and look for more effective treatments

The model has been created by injecting tumor cells from a patient into a mouse to mimic the transformation of leukemia into a more aggressive form, making it possible to learn about the real evolution of the disease and be able to test new treatments.

Leer más about Scientists create a mouse model to study the progression of a type of leukemia and look for more effective treatments

IDIBELL receives 25.907€ thanks to the donations of Bonpreu and Esclat customers

In November, Bonpreu and Esclat clients made 185.804 donations that have made it possible to obtain 25.907€ for IDIBELL to develop new therapies for diabetes through the Solidarity Roundup, a tool developed by Worldcoo.

Leer más about IDIBELL receives 25.907€ thanks to the donations of Bonpreu and Esclat customers

30 IDIBELL researchers among the most cited scientists in the world

The World’s Top 2% Scientists ranking is published every year by Stanford University and lists around 180.000 researchers from 22 scientific fields.

Leer más about 30 IDIBELL researchers among the most cited scientists in the world

An IDIBELL project is a finalist in the VTSO Health Innovation Award

The three finalists have been selected from around thirty projects from Catalan hospitals or healthcare innovation centres. The prize is worth 15,000 euros and has the collaboration of IDIBELL-XarSMART.

Leer más about An IDIBELL project is a finalist in the VTSO Health Innovation Award

The first RegenBell symposium on stem cells and regenerative medicine takes place

On November 27 and 28, the first edition of the RegenBell symposium on stem cells and regenerative medicine took place, organized by IDIBELL’s Regenerative Medicine Program (RegenBell). The event was attended by more than 165 people.

Leer más about The first RegenBell symposium on stem cells and regenerative medicine takes place

PAPILLOMATTACK: the card game to learn about the human papillomavirus enters into the L’Hospitalet classrooms

Based on gamification, the PAPILLOMATTACK science education project teaches what the human papillomavirus is, which diseases it causes and how it can be prevented with vaccination and screening programs

Leer más about PAPILLOMATTACK: the card game to learn about the human papillomavirus enters into the L’Hospitalet classrooms

The ”la Caixa” Foundation promotes a promising study against pancreatic cancer

In total, 33 new basic, clinical or translational research projects of scientific excellence and social impact in the fields of study of cardiovascular diseases and infections, oncology and neurosciences will receive 25.3 million euros.

Leer más about The ”la Caixa” Foundation promotes a promising study against pancreatic cancer

A study by IDIBELL, ICO and IGTP puts precision medicine at the service of nerve tumors

This improvement opens the door to more personalized therapeutic strategies and has been reflected in an article recently published in the journal Molecular Oncology.

Leer más about A study by IDIBELL, ICO and IGTP puts precision medicine at the service of nerve tumors
Scroll to Top